Enterovirus causing progression of heart failure in a patient with a history of myocardial infarction

Hellenic Journal of Cardiology

Volumn 56, Issue 4, 2015, Pages 332-337

  Pawlak, Agnieszka ^a   Przybylski, Maciej ^b   Frontczak Baniewicz, Małgorzata ^c   Gil, Katarzyna ^a   Nasierowska Guttmejer, Anna M ^c   Gil, Robert J ^c  

^a CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF INTERIOR   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA INTERFERON; TROPONIN I; ANTIVIRUS AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTRON MICROSCOPY; ENTEROVIRUS; FEMALE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MYOCARDITIS; REAL TIME POLYMERASE CHAIN REACTION; ENTEROVIRUS INFECTIONS; ISOLATION AND PURIFICATION; MYOCARDIAL INFARCTION; PATHOLOGY; VIROLOGY;

ANTIVIRAL AGENTS; DISEASE PROGRESSION; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FEMALE; HEART FAILURE; HUMANS; INTERFERON-BETA; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 84939425831     PISSN: 11099666     EISSN: 22415955     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006; 113: 1424-1433.
2. Lv S, Rong J, Ren S, et al. Epidemiology and diagnosis of viral myocarditis. Hellenic J Cardiol. 2013; 54: 382-391.
3. Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013; 34: 2636-2648, 2648a-2648d.
4. Cooper LT Jr. Myocarditis. N Engl J Med. 2009; 360: 1526-1538.
5. Schultheiss HP, Kühl U, Cooper LT. The management of myocarditis. Eur Heart J. 2011; 32: 2616-2625.
6. Chrysohoou C, Tsiamis E, Brili S, Barbetseas J, Stefanadis C. Acute myocarditis from Coxsackie infection, mimicking subendocardial ischaemia. Hellenic J Cardiol. 2009; 50: 147-150.
7. Sagar S, Liu PP, Cooper LT Jr. Myocarditis. Lancet. 2012; 379: 738-747.
8. Friedrich MG, Sechtem U, Schulz-Menger J, et al; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009; 53: 1475-1487.
9. Mavrogeni S, Manoussakis MN. Myocarditis as a complication of influenza A (H1N1): evaluation using cardiovascular magnetic resonance imaging. Hellenic J Cardiol. 2010; 51: 379-380.
10. Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J. 2007; 28: 3076-3093.
11. Kühl U, Pauschinger M, Seeberg B, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation. 2005; 112: 1965-1970.
12. Kawai C, Matsumori A. Dilated cardiomyopathy update: infectious- immune theory revisited. Heart Fail Rev. 2013; 18: 703-714.
13. Ikeda T, Saito T, Takagi G, et al. Acute myocarditis associated with coxsackievirus B4 mimicking influenza myocarditis: electron microscopy detection of causal virus of myocarditis. Circulation. 2013; 128: 2811-2812.
14. Kühl U, Pauschinger M, Schwimmbeck PL, et al. Interferonbeta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 2003; 107: 2793-2798.